Mirion Technologies, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders??? Equity

Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Millions	Total	Public warrants exercises	Private warrants exchange	Conversion of shares of class B common stock to class A common stock	Class A Common Stock	Class B Common Stock	Common Stock Class A Common Stock	Common Stock Class A Common Stock Public warrants exercises	Common Stock Class A Common Stock Private warrants exchange	Common Stock Class A Common Stock Conversion of shares of class B common stock to class A common stock	Common Stock Class B Common Stock	Common Stock Class B Common Stock Conversion of shares of class B common stock to class A common stock	Treasury Stock	Additional Paid-In Capital	Additional Paid-In Capital Public warrants exercises	Additional Paid-In Capital Private warrants exchange	Additional Paid-In Capital Conversion of shares of class B common stock to class A common stock	Accumulated Deficit	Accumulated Other Comprehensive (Loss) Income	Noncontrolling Interests	Noncontrolling Interests Conversion of shares of class B common stock to class A common stock
Beginning balance (in shares) at Oct. 19, 2021					9,976,164
Ending balance (in shares) at Oct. 20, 2021					18,750,000	18,750,000
Beginning balance (in shares) at Dec. 31, 2022							200,298,834				8,040,540
Beginning balance at Dec. 31, 2022	$ 1,467.2						$ 0.0				$ 0.0		$ 0.0	$ 1,882.4				$ (408.5)	$ (75.7)	$ 69.0
Beginning balance (in shares) at Dec. 31, 2022													0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Warrant redemptions / Conversion of shares (in shares)							100			193,207		(193,207)
Conversion of shares and warrants exercises/exchange				$ 0.0													$ 1.6				$ (1.6)
Stock issued for vested restricted stock units (in shares)							40,764
Stock compensation to directors in lieu of cash compensation (in shares)							12,090
Stock compensation to directors in lieu of cash compensation	0.1													0.1
Issuance of shares of class A common stock, net of offering costs (in shares)							17,142,857
Issuance of shares of class A common stock, net of offering costs	149.8													149.8
Stock-based compensation expense	5.5													5.5
Net loss	(42.9)																	(41.9)		(1.0)
Other comprehensive income (loss)	8.3																		8.0	0.3
Ending balance (in shares) at Mar. 31, 2023							217,687,852				7,847,333
Ending balance at Mar. 31, 2023	1,588.0						$ 0.0				$ 0.0		$ 0.0	2,039.4				(450.4)	(67.7)	66.7
Ending balance (in shares) at Mar. 31, 2023													0
Beginning balance (in shares) at Dec. 31, 2022							200,298,834				8,040,540
Beginning balance at Dec. 31, 2022	1,467.2						$ 0.0				$ 0.0		$ 0.0	1,882.4				(408.5)	(75.7)	69.0
Beginning balance (in shares) at Dec. 31, 2022													0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(84.2)
Other comprehensive income (loss)	(6.9)
Ending balance (in shares) at Sep. 30, 2023							217,960,513				7,832,333
Ending balance at Sep. 30, 2023	1,543.3						$ 0.0				$ 0.0		$ (0.7)	2,052.0				(490.2)	(82.4)	64.6
Ending balance (in shares) at Sep. 30, 2023													87,647
Beginning balance (in shares) at Mar. 31, 2023							217,687,852				7,847,333
Beginning balance at Mar. 31, 2023	1,588.0						$ 0.0				$ 0.0		$ 0.0	2,039.4				(450.4)	(67.7)	66.7
Beginning balance (in shares) at Mar. 31, 2023													0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock issued for vested restricted stock units (in shares)							323,350
Stock repurchased to satisfy tax withholding for vesting restricted stock units (in shares)							87,647						87,647
Stock repurchased to satisfy tax withholding for vesting restricted stock units	(0.7)												$ (0.7)
Stock compensation to directors in lieu of cash compensation (in shares)							9,782
Stock compensation to directors in lieu of cash compensation	0.1													0.1
Stock-based compensation expense	6.1													6.1
Net loss	(28.4)																	(27.7)		(0.7)
Other comprehensive income (loss)	(0.6)																		(0.6)	0.0
Ending balance (in shares) at Jun. 30, 2023							217,933,337				7,847,333
Ending balance at Jun. 30, 2023	1,564.5						$ 0.0				$ 0.0		$ (0.7)	2,045.6				(478.1)	(68.3)	66.0
Ending balance (in shares) at Jun. 30, 2023													87,647
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Warrant redemptions / Conversion of shares (in shares)										15,000		(15,000)
Conversion of shares and warrants exercises/exchange				0.0													0.1				(0.1)
Stock issued for vested restricted stock units (in shares)							2,204
Stock compensation to directors in lieu of cash compensation (in shares)							9,972
Stock compensation to directors in lieu of cash compensation	0.1													0.1
Stock-based compensation expense	6.2													6.2
Net loss	(12.9)																	(12.1)		(0.8)
Other comprehensive income (loss)	(14.6)																		(14.1)	(0.5)
Ending balance (in shares) at Sep. 30, 2023							217,960,513				7,832,333
Ending balance at Sep. 30, 2023	1,543.3						$ 0.0				$ 0.0		$ (0.7)	2,052.0				(490.2)	(82.4)	64.6
Ending balance (in shares) at Sep. 30, 2023													87,647
Beginning balance (in shares) at Dec. 31, 2023					218,177,832	7,787,333	218,177,832				7,787,333
Beginning balance at Dec. 31, 2023	$ 1,550.0						$ 0.0				$ 0.0		$ (1.3)	2,056.5				(505.4)	(65.3)	65.5
Beginning balance (in shares) at Dec. 31, 2023	149,076												149,076
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Warrant redemptions / Conversion of shares (in shares)										460,910		(460,910)
Conversion of shares and warrants exercises/exchange				0.0													3.8				(3.8)
Stock issued for vested restricted stock units (in shares)							88,171
Stock compensation to directors in lieu of cash compensation (in shares)							8,420
Stock compensation to directors in lieu of cash compensation	$ 0.1													0.1
Stock-based compensation expense	3.5													3.5
Net loss	(26.5)																	(25.8)		(0.7)
Other comprehensive income (loss)	(9.2)																		(8.9)	(0.3)
Ending balance (in shares) at Mar. 31, 2024							218,735,333				7,326,423
Ending balance at Mar. 31, 2024	1,517.9						$ 0.0				$ 0.0		$ (1.3)	2,063.9				(531.2)	(74.2)	60.7
Ending balance (in shares) at Mar. 31, 2024													149,076
Beginning balance (in shares) at Dec. 31, 2023					218,177,832	7,787,333	218,177,832				7,787,333
Beginning balance at Dec. 31, 2023	$ 1,550.0						$ 0.0				$ 0.0		$ (1.3)	2,056.5				(505.4)	(65.3)	65.5
Beginning balance (in shares) at Dec. 31, 2023	149,076												149,076
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	$ (52.5)
Other comprehensive income (loss)	$ 5.8
Ending balance (in shares) at Sep. 30, 2024	18,750,000				225,468,851	6,790,790	225,468,851				6,790,790
Ending balance at Sep. 30, 2024	$ 1,574.9						$ 0.0				$ 0.0		$ (2.2)	2,137.2				(556.5)	(59.6)	56.0
Ending balance (in shares) at Sep. 30, 2024	232,842												232,842
Beginning balance (in shares) at Mar. 31, 2024							218,735,333				7,326,423
Beginning balance at Mar. 31, 2024	$ 1,517.9						$ 0.0				$ 0.0		$ (1.3)	2,063.9				(531.2)	(74.2)	60.7
Beginning balance (in shares) at Mar. 31, 2024													149,076
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Warrant redemptions / Conversion of shares (in shares)								3,978,418	1,768,000	468,133		(468,133)
Conversion of shares and warrants exercises/exchange		$ 42.3	$ 18.3	0.0											$ 42.3	$ 18.3	3.9				(3.9)
Stock issued for vested restricted stock units (in shares)							485,972
Stock repurchased to satisfy tax withholding for vesting restricted stock units (in shares)							83,766						83,766
Stock repurchased to satisfy tax withholding for vesting restricted stock units	(0.9)												$ (0.9)
Stock compensation to directors in lieu of cash compensation (in shares)							7,702
Stock compensation to directors in lieu of cash compensation	0.1													0.1
Stock-based compensation expense	3.9													3.9
Net loss	(12.0)																	(11.7)		(0.3)
Other comprehensive income (loss)	(5.5)																		(5.3)	(0.2)
Ending balance (in shares) at Jun. 30, 2024							225,359,792				6,858,290
Ending balance at Jun. 30, 2024	1,564.1						$ 0.0				$ 0.0		$ (2.2)	2,132.4				(542.9)	(79.5)	56.3
Ending balance (in shares) at Jun. 30, 2024													232,842
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Warrant redemptions / Conversion of shares (in shares)										67,500		(67,500)
Conversion of shares and warrants exercises/exchange				$ 0.0													$ 0.5				$ (0.5)
Stock issued for vested restricted stock units (in shares)							33,367
Stock compensation to directors in lieu of cash compensation (in shares)							8,192
Stock compensation to directors in lieu of cash compensation	0.1													0.1
Stock-based compensation expense	4.2													4.2
Net loss	(14.0)																	(13.6)		(0.4)
Other comprehensive income (loss)	$ 20.5																		19.9	0.6
Ending balance (in shares) at Sep. 30, 2024	18,750,000				225,468,851	6,790,790	225,468,851				6,790,790
Ending balance at Sep. 30, 2024	$ 1,574.9						$ 0.0				$ 0.0		$ (2.2)	$ 2,137.2				$ (556.5)	$ (59.6)	$ 56.0
Ending balance (in shares) at Sep. 30, 2024	232,842												232,842